1.
Efficacy Of Loralatinib After Combination With Alectinib Central Lung Disease In One Patient In Kinase-Positive Anaplastic Lymphoma Small Cell Lung Cancer: A Case Report. Clinical and Medical Case Reports. 2022;2(01):31-34. Accessed January 23, 2025. https://currentopinion.info/index.php/cmcr/article/view/76